Effect of DHA-Alb on long term survival after MCAo. (a) Behavioral outcome after stroke (normal score = 0, maximal deficit = 12) during 60 min of MCAo and various time after MCAo. (b) Histopathology at three weeks after stroke. DHA-Alb treatment improved total neurological score and reduced tissue loss on week four after stroke. Values shown are means ± SEM. ^#p< 0.05 versus saline group; ^∗p< 0.05 DHA-Alb versus Alb group (repeated measures ANOVA followed by Bonferroni tests).